NLRP3 and colitis: These findings collectively indicate that VIS effectively ameliorates DSS-induced colitis by modulating NF-κB, COX-2, TNF-α, and NLRP3 expression while enhancing occludin and Nrf2 levels, thereby reducing inflammation and oxidative stress and restoring intestinal barrier integrity.